LEADER 03527nam  22005535  450 
001 9910488726203321
005 20251113210927.0
010   $a3-030-74103-6
024 7 $a10.1007/978-3-030-74103-7
035   $a(CKB)5590000000516554
035   $a(MiAaPQ)EBC6675937
035   $a(Au-PeEL)EBL6675937
035   $a(OCoLC)1260345264
035   $a(PPN)269153144
035   $a(DE-He213)978-3-030-74103-7
035   $a(EXLCZ)995590000000516554
100   $a20210625d2021      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aControversies in Neuro-Ophthalmic Management $eAn Evidence and Case-Based Appraisal /$fedited by Amanda D. Henderson, Andrew R. Carey
205   $a1st ed. 2021.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021.
215   $a1 online resource (282 pages)
225 1 $aMedicine Series
311 08$a3-030-74102-8 
327   $aI. Introduction -- 1. Purpose of this Book -- II. Optic neuropathies -- 2. Non-arteritic anterior ischemic optic neuropathy -- 3. Radiation optic neuropathy -- 4. Optic neuritis -- 5.Traumatic optic neuropathy -- 6. Papilledema -- 7. Leukemic infiltration of the optic nerve -- 8. Infectious optic neuropathy -- 9. Hereditary optic neuropathy -- 10. Compressive optic neuropathy -- III. Ocular motility disorders -- 11. Transient diplopia -- 12. Third nerve palsy -- 13. Sixth nerve palsy -- 14. Fourth nerve palsy -- 15. Multiple cranial neuropathies -- 16. Nystagmus -- IV. Transient visual symptoms -- 17. Transient monocular vision loss -- 18. Transient binocular vision loss -- 19. Visual aura -- V. Pain -- 20. Migraine -- 21. Trigeminal autonomic cephalgia headaches -- 22. Post-concussive syndrome -- VI. Systemic disease -- 23. Giant cell arteritis -- 24. Myasthenia gravis.-25. ophthalmopathy -- 26. Sarcoidosis.
330   $aThis book functions as a resource for providers who treat patients with neuro-ophthalmic conditions. Using an evidence-based approach to controversial management decisions, the material is presented in a digestible, case-based format. Divided into six sections, the book begins with an introduction to its framework, format, and purpose. Following this, sections two, three, and four discuss various optic neuropathies, ocular motility disorders, and transient visual symptoms. The concluding sections then address neuro-ophthalmic manifestations of pain, including migraine and post-concussive syndrome, and systemic diseases, such as giant cell arteritis. Each chapter focuses on cases that are historically complex, or which have undergone a recent shift in traditional management due to new scientific discoveries or newly available therapies. Controversies in Neuro-Ophthalmic Management presents essential, thorough information on management options and the data for their use to provide the best care for patients.
410  0$aMedicine Series
606   $aOphthalmology
606   $aNeurology
606   $aOphthalmology
606   $aNeurology
615  0$aOphthalmology.
615  0$aNeurology.
615 14$aOphthalmology.
615 24$aNeurology.
676   $a617.7
702   $aCarey$b Andrew R.
702   $aHenderson$b Amanda D.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910488726203321
996   $aControversies in Neuro-Ophthalmic Management$92803386
997   $aUNINA